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Oxygen Extraction Ratio (OER) as a 
Measurement of Hemodialysis (HD) 
Induced Tissue Hypoxia: A Pilot 
Study
Silverio Rotondi1, Lida Tartaglione1, Maria Luisa Muci1, Alessio Farcomeni  2, Marzia Pasquali3 & 
Sandro Mazzaferro  1,4
HD tissue hypoxia associates with organ dysfunctions. OER, the ratio between SaO2 and central-
venous-oxygen-saturation, could estimate oxygen requirements during sessions, but no data are 
available. We evaluated OER behavior in 20 HD patients with permanent central venous catheter (CVC) 
as vascular access. Pre-HD OER (33.6 ± 1.4%; M ± SE) was higher than normal (range 20–30%). HD 
sessions increased OER to 39.2 ± 1.5% (M ± SE; p < 0.05) by 30′ and to 47.4 ± 1.5% (M ± SE; p < 0.001) 
by end of treatment (delta 40%). During HD sessions of the long and short interdialytic intervals, OER 
values overlapped, suggesting no influence of patient’s hydration status shifts. OER increased (p < 0.05) 
after 30′ of isolated HD (zero ultrafiltration), but not during isolated ultrafiltration (zero dialysate flow), 
suggesting a role for blood-membrane-dialysate interaction, independent of volume reduction. In ten 
patients, individual variability of pre-HD OER was low and repeatable (maximum calculated difference 
over time 6.6%), and negatively correlated with HD-induced OER increments (r = 0.860; p < 0.005), 
suggesting a decline in the adaptive response along with resting OER increments. In 30 prevalent 
patients, adjusted multivariate analysis showed that pre-HD OER (HR = 0.88, CI 0.79–0.99, p = 0.028) 
and percent HD-induced OER (HR = 1.04, CI 1.01–1.08, p = 0.015) were both associated with mortality, 
with threshold values respectively <32% and >40%. In HD patients with CVC as vascular access, OER 
is a cheap, easily measurable and repeatable parameter useful to assess intradialytic hypoxia, and a 
potential biomarker of HD related stress and morbidity, helpful to recognize patients at increased risk of 
mortality.
Hemodialysis (HD) sessions imply rapid changes in patients’ blood volume and composition, responsible for 
the so-called “dialytic stress”, which includes intradialytic events (cramps, headache and hypotension) and post 
HD fatigue. There is evidence that besides clinical symptoms, HD sessions induce some mild degree of organ 
ischemia mostly occurring without symptoms, but responsible for transient dysfunction (e.g. myocardial stun-
ning or chronic ischemic brain injury), and, in the long term, for organ damage1–3. These subtle intradialytic 
ischemic episodes are clearly referable to a mismatch between oxygen delivery and oxygen consumption3 induced 
by rapid blood volume reduction4 and/or other HD related biochemical changes (e.g. pH shifts or complement 
activation). Non-HD related factors like low resting arterial oxygen saturation (SaO2) secondary to pulmonary 
or cardiovascular diseases or anemia can clearly add to the risk and severity of this phenomenon4–7. Currently, 
it is not possible to reliably assess the occurrence and entity of peripheral oxygen mismatch during HD4,6, while, 
from a pathophysiologic point of view, this could represent a useful parameter to monitor. We hypothesized that 
Oxygen Extraction Ratio (OER), i.e. the ratio between SaO2 and central venous oxygen saturation (ScvO2), which 
is a reliable and commonly employed parameter to assess oxygen consumption, could be useful for this purpose. 
Normal OER averages 20–30% and can increase up to 70% in healthy humans during cycle exercise8. In addition, 
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values over 50% are considered indicative, in intensive care unit (ICU) patients, of hemodynamic shock, worse 
prognosis and lower survival rate9–11. Nephrologists, who are less familiar with respiratory parameters of acid base 
balance, may be reluctant to use OER. Further, ScvO2, the second parameter necessary to calculate OER, cannot 
be measured in every hemodialysis patient, but only in those with central venous catheter (CVC) as vascular 
access. Actually, to the best of our knowledge, no OER data are available in HD patients and only few papers deal 
with ScvO2, which is less precise than OER.
To verify if OER could represent a way of monitoring tissue response and adaptation to intradialytic stress, 
we planned the present study to evaluate in detail the relationship between OER and HD. Our aims were the fol-
lowing: to describe the changes, if any, of OER during HD sessions; to evaluate if OER is sensibly affected by the 
interdialytic changes in patient’s hydration status; to verify if OER is differently induced by isolated UF dialysis 
(iUF) or isolated Diffusion dialysis (iD); to establish its stability in the individual patient, and to evaluate possible 
associations with clinical outcomes.
Materials and Methods
Study design and subjects. We planned a prospective, single Center, observational study involving all 
the HD patients receiving treatment thrice weekly in our Unit at Polo Pontino, Sapienza University of Rome, 
by means of a CVC. The protocol study, which included an intensive phase with repetitive OER measurements 
within 3 weeks, and a longer clinical observation period of at least three months, was submitted and approved by 
the local EC (ASL Rm2; prot. N°107055/2017) and was in accordance with the declaration of Helsinki. Eligible 
patients gave informed consent. Inclusion criteria were: age ≥18 years, chronic HD treatment since at least three 
months by means of permanent jugular CVC, no evidence of acute underlying illness. Exclusion criteria from 
the intensive phase were: presence of arteriovenous fistula, fistula surgery scheduled within 30 days, evidence of 
displaced or malfunctioning CVC, Chronic Obstructive Pulmonary Disease or SaO2 < 90% in resting condition, 
severe refractory anaemia (Hb < 9 g/dl despite adequate Erythropoietin and iron supplement therapy), conges-
tive heart failure (NYHA class ≥ II) and severe peripheral vascular ischemia. From a total of 30 prevalent cases 
with CVC, 10 were excluded from the intensive phase (three because of contemporary presence of AVF, three 
because of AVF placement scheduled within one month, three because of severe peripheral vascular ischemia 
and one because was going to move to another Unit). The remaining twenty cases entered the intensive phase, 
and were allocated into small groups to be studied within a maximum of 10 consecutive HD treatments, as illus-
trated in Fig. 1. In this group, the entity of OER changes during HD and the influence of patient’s hydration status 
were evaluated during the first 4 HD sessions. For this purpose, we sampled OER six times during each session 
(OER6m = before HD and after 15′, 30′, 60′, 120′, and end of treatment) in order to obtain two trends after the 
long interdialytic intervals (sessions 1 and 4, identified as HDLong,) and two trends after the short interdialytic 
intervals (sessions 2 and 3, identified as HDShort) (Fig. 1). The relative roles of dialysis and ultrafiltration (UF) 
were studied during the 5th and 6th HD sessions, again by measuring OER 6 times (OER6m). During the first hour 
of these HDshort sessions, either dialysate flow (HD-iUF) or ultrafiltration (HD-iD) were excluded, while stand-
ard treatment was resumed in the following hours. To increase homogeneity, in ten patients the sequence was 
first HD-iUF and then HD-iD, while in ten it was in the reverse order (first HD-iD and then HD-iUF) (Fig. 1). 
OER values of the iUF and of the iD sessions were then pooled together, independently of the collection order. 
Further, to evaluate variability and repeatability of OER in the individual patient, we measured it only twice 
(OER2m = before and at the end of treatment) in the HD sessions from 7 to 10, in ten randomly allocated patients. 
Figure 1. Flow chart of the study. 20 patients were enrolled for the intensive phase of the study which lasted for 
ten consecutive hemodialysis sessions. In every subject, OER was measured six times during each of the first 6 
HD sessions, while in dialysis sessions 7 to 10 OER was measured only twice, in ten patients only. Ten further 
patients were enrolled for the clinical follow-up phase. HDLong = Hemodialysis following long interdialytic 
interval; HDShort = Hemodialysis following short interdialytic interval; iD = isolated dialysis; iUF = isolated 
ultrafiltration.
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By pooling these data with values of sessions 1 to 6, a total of ten consecutive pre- and post-HD OER values were 
obtained in ten patients.
Finally, to explore the possible relationship of OER with clinical outcomes, we considered the whole popula-
tion of 30 prevalent patients since in all of them we had at least two time-spaced OER measurements (obviously 
obtained before AVF placement) within a minimum follow-up of 3 months.
Blood for gas analysis was sampled from the arterial line of the dialysis equipment at the established times. To 
avoid pre-analytical artifacts, handling of blood for gas analysis was standardized according to the manufacturer′s 
instructions. During all the HD study-sessions, patients wore a finger oximeter for SaO2 measurement, whose 
values were recorded concomitantly to blood samplings.
Measurements and Instruments. OER was calculated with the following formula:
= − × .OER [(SaO ScvO )/SaO ] 1002 2 2
SaO2 was monitored during all the HD study-sessions by means of a peripheral pulse-oximetry device (Max 
Puls Two, Eurosanitas Italy; accuracy of SaO2 measurement = 2%). ScvO2 was measured at established times 
during HD sessions by sampling blood from the arterial line of the dialysis circuit and immediately performing 
blood gas analysis with a dedicated equipment (GEM 4000 premier, Instrumentation Laboratory Italy; accuracy 
of SO2 measurement = 2%).
Hemodialysis. All patients received standard bicarbonate dialysis, according to their individual prescriptions 
of electrolyte concentrations and blood and dialysate flows. Dialyzer membrane was polyaril etheresulphone in 
all, with surface tailored to the patient body surface. Dialysis machines were all equipped with devices to record 
the relative changes in blood volume (BV) produced during therapy. The standard policy of our Center is to keep 
ultrafiltration rate at ≤ 10 ml/kg/h with a dialysate temperature between 35.5 and 36.0 °C.
Statistical analysis. Data are reported as median (and IQR, 50%) or mean (±SE) as appropriate. Absolute 
and relative differences of parameters between consecutive visits were computed and described. Statistical signif-
icance of various predictors and time was evaluated by mixed-effects linear regression, where a subject-specific 
random effect was used to capture dependence arising from repeated measures on the same subject. The global 
level for statistical significance was pre-specified as 5%, where multiple tests were adjusted through Bonferroni 
correction. In order to evaluate stability/replicability of OER measurements we computed the subject-specific 
relative differences. As customary, stability was defined as lack of trends and stagionality over time, and maxi-
mal estimated subject-specific relative difference below 10%. Association of relevant predictors (pre-HD OER, 
HD-induced OER) with time-to-event outcomes was evaluated through stratified Kaplan-Meier curves and asso-
ciated log-rank tests and/or univariate Cox regression models. At multivariate analyses we used Cox regression 
models, where the final set of predictors was selected by means of forward selection based on Akaike Information 
Criterion. Predictors of pre-HD OER and HD-related OER changes were assessed by means of linear regression 
models.
The software used was R version 3.3.3 (R development core team).
The datasets generated and analysed during the current study are available from the corresponding Author 
on reasonable request.
Results
Main clinical and biochemical characteristics of the whole prevalent population, of the 20 patients enrolled in the 
intensive phase, and, by comparison, of the 10 patients excluded from this phase are shown in Table 1. There were 
13 males and 17 females, aged 77 ± 2.3 years, receiving substitutive therapy since an average of 3.0 years (range 
1–11 years). Three were obese (10%), eleven (36%) had diabetes and eight (26%) had vascular co-morbidities. 
As evidenced in the table, length of stay on dialysis (3.7 ± 0.7 vs 2.4 ± 0.6 years, M ± SE; p < 0.02) and BMI 
(25.1 ± 1.2 vs 22.1 ± 0.7, M ± SE; p < 0.03) were the only clinical and biochemical differences between the two 
sub-populations of 20 and, respectively, 10 patients.
Effects on OER of standard HD session and of hydration status (study sessions 1 to 4). OER 
values recorded during the HDlong sessions 1 and 4, consistently overlapped and were averaged. Mean pre-HD 
OER was higher than the normal reference range (33.6 ± 1.4% vs a recommended range of 20–30%). During 
therapy, OER increased by 17 ± 4% (p < 0.05; Fig. 2) since after 30′ and continued to increase progressively up 
to + 40 ± 4% (p < 0.001; Fig. 2) at the end of treatment. The absolute OER values during each HDLong session are 
reported in Table 2. SaO2 (basal value 97.3 ± 0.3, M ± SEM) was remarkably stable during the whole sessions 
(values provided in Supplemental Table 1). As expected, ScvO2 and BV decreased progressively and significantly 
(p < 0.001; Supplemental Fig. 1a,b), and no correlation existed between OER (either absolute values or percent 
change) and BV. In these two HDlong sessions, with an average UF rate of 9.7 ml/Kg/h (total UF = 2.2 ± 0.11 L), no 
clinical symptom occurred and blood pressure and heart rate did not change (Supplemental Table 1).
Similarly to HDLong, OER values consistently overlapped before and during treatment in the HDshort sessions 
2 and 3, and we averaged them. The OER increment was significant since after 30′ (+19 ± 4%; p < 0.05) and 
progressively peaked at +38 ± 3% (p < 0.001) by the end of therapy, showing, as illustrated in Fig. 2, an almost 
perfect overlap with values during HDLong. The absolute values of OER during each HDShort session are given in 
Table 2. SaO2 (basal value 97.3 ± 0.2, M ± SEM), showed remarkable stability (Supplemental Table 1). ScvO2 and 
BV progressively decreased (p < 0.001; Supplemental Fig. 1a,b), again without correlation between OER and BV. 
In these two HDshort sessions, Uf averaged 7.7 ml/Kg/h (total Uf = 2.1 ± 0.60 L), without clinical symptoms and 
without differences in blood pressure and heart rate (Supplemental Table 1).
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Patients (n = 30) (n = 20) (n = 10)
20 vs 10 
p<
Men/Females; n (%) 13 (43)/17 (57) 8 (40)/12 (60) 5 (50)/5(50) n.s
Age, yr 77 ± 2.3 75 ± 2.9 76 ± 2.9 n.s
Vintage HD, yr 3.0 ± 0.7 3.7 ± 0.7 2,4 ± 0.6 0.02
BMI, Kg/m2 24.1 ± 1.3 25.1 ± 1.2 22.1 ± 0,7 0.03
ABI 0.6 ± 0.06 0.7 ± 0.06 0.6 ± 0.05 n.s
Comorbidities; n (%) 15 (50) 12 (60) 3 (30) n.s (#)
Obesity (BMI > 30) 3 (10) 2 (10) 1 (3)
Diabetes, n (%) 11 (36) 7 (35) 4 (13)
Vascular co-morbidities* 8 (25) 5 (25) 3 (30)
Hb, g/dl 10.0 ± 0.4 10.3 ± 0.3 9.4 ± 0.4 n.s
Calcium, mg/dl 8.4 ± 0.3 8.5 ± 0.1 8.3 ± 0.22 n.s
Phosphate, mg/dl 5.0 ± 0.5 5.2 ± 0.3 4.6 ± 0.6 n.s
PTH, pg/ml 286 ± 30 338 ± 35 272 ± 26 n.s
ALP, UI/L 79 ± 5,1 84 ± 5,9 81 ± 10 n.s
CRP, mg/dl 2.2 ± 0.5 2.1 ± 0.6 1.5 ± 0.6 n.s
ESR, mm 36 ± 4.7 36 ± 4.7 24 ± 14 n.s
Ferritin, mcg/l 345 ± 43 321 ± 46 337 ± 84 n.s
Transferrin, mg/dl 174 ± 12 179 ± 13 148 ± 16 n.s
Albumin, g/dl 3.1 ± 0.1 3.3 ± 0.06 2.9 ± 0.20 n.s
KT/V 1.40 ± 0.06 1.48 ± 0.04 1.37 ± 0.05 n.s
nPCR, g/Kg/day 1.00 ± 0.07 1.03 ± 0.04 0.95 ± 0.03 n.s
Table 1. Clinical and biochemical characteristics of the whole prevalent population, othe the 20 patients 
enrolled in the intensive phase and, by comparison, of the 10 patients excluded from this phase. Data are 
M ± SE. *Vascular co-morbidities = Peripheral ischemia and acute Coronary Syndrome. BMI: Body Mass Index; 
ABI: Ankle Brachial Index; Hb: Haemoglobin; PTH: intact Parathyroid hormone; ALP: Alkaline Phosphate; 
CRP: C-reactive protein; ESR: Erythrocyte Sedimentation Rate; nPCR: normalized Protein Catabolic Rate. All 
comparisons are t-test, except for X2 test (#) applied for comorbidities.
Figure 2. Both HDLong (ANOVA, p < 0.001) and HDShort (ANOVA, p < 0.001) sessions increased OER values. 
In particular, increments were significant since after 30′ (+17 ± 4% and +19 ± 4% during HDLong and HDShort 
respectively; M ± SE; p < 0.05 for both), and reached a final rise of +40 ± 4% with HDLong and +38 ± 3% with 
HDShort. No difference was evident between the two sessions. Bonferroni post-hoc test vs basal values: *p < 0.05; 
#p < 0.005; °p < 0.001; for both sessions.
HD 
session 0′ 15′ 30′ 60′ 120′ 240′ Anova
HDlong1 34.5 ± 1.7 39.3 ± 1.6 40.2 ± 1.8* 41.3 ± 1.4# 43.4 ± 2.0° 47.8 ± 1.4° <0.001
HDlong2 33.1 ± 1.4 37.3 ± 1.3 38.2 ± 1.3* 39.3 ± 1.5# 42.4 ± 1.8° 47.0 ± 1.7° 0.001
HDShort1 33.8 ± 1.9 40.2 ± 2.7 41.3 ± 1.8* 42.4 ± 1.6# 42.0 ± 2.1° 45.9 ± 2.4° <0.004
HDShort2 36.2 ± 2.0 40.6 ± 2.9 42.2 ± 2.4* 42.0 ± 2.6* 42.9 ± 3.2* 45.9 ± 2.3° 0.003
Table 2. OER values (M ± SE) during HDlong and HDshort sessions in 20 patients. Bonferroni Post-hoc test vs 
basal values: *p < 0.05; # p < 0.005; °p < 0.001.
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Effects on OER of iD and iUF (sessions 5 and 6). The relative roles of iD and iUF were evaluated during 
the first hour of the 5th and 6th HDshort sessions, in an alternate sequence involving two groups of ten patients 
each (Fig. 1). During iD, UF rate was kept to the minimum allowed by the machine, while during iUF, dialysate 
flow was set to zero. After 15′, 30′ and 60′, OER increased by 17 ± 4, 22 ± 4 and 21 ± 5% during iD and respec-
tively by 10 ± 3, 12 ± 4 and 15 ± 4% during iUF. Compared to basal, these increments were significant during iD 
(ANOVA, p < 0.05) but not during iUF. Further, during iD the OER increment was greater than during iUF after 
15′ (p < 0.05) and 30′ (p < 0.01) but not after 60′ (Fig. 3). The absolute values of OER during iD and iUF sessions 
are shown in Table 3. During this observation, blood pressure and SaO2 were stable (Supplement Table 1), while 
ScvO2 and BV dropped both during iD (p < 0.01 and p < 0.05, respectively, Supplemental Fig. 1c,d), while only 
BV dropped during iUF (p < 0.01; Supplemental Fig. 1d). The drop of BV with iUF was greater than with iD at 30′ 
(p < 0.01) and at 60′ (p < 0.05; Supplemental Fig. 1d). When standard HD therapy was resumed, OER values pro-
gressively increased became closer, and reached final, comparable, post-HD values of 47 ± 2.0% and 46 ± 1.6%, 
respectively (Table 3 and Supplemental Fig. 2).
OER stability (OER2m, study sessions 7 to 10). In ten patients, we measured OER only before and 
after HD (OER2m) in four more sessions and pooled the results with those available in the previous sessions. The 
individual variability of pre- and post-HD OER (M, IQR and range) observed in these patients is illustrated in 
Fig. 4, where values are ordered in progressively increasing basal values. The maximum calculated difference over 
time of baseline OER in the individual patients was 6.6%, pointing to substantial stability and repeatability of the 
parameter. To be noticed, in this figure post-HD OER did not increase along with the increasing basal values. 
Indeed, as illustrated in Fig. 5, we found a strong negative relationship between pre-HD OER and OER incre-
ments in these ten patients (r = −0.860; p < 0.005). This relationship was confirmed to be negative and significant 
even in the whole population of twenty patients (r = −0.583; p < 0.01) and, separately, in the other ten patients 
(r = −0.688; p < 0.02) in whom we had a single value of pre- and post-HD OER.
OER and mortality. In the whole population of 30 patients, during a follow-up of 15 ± 1.5 months (range 
3–23), we recorded 13 deaths (four infections (13%), three coronary heart disease (10%), three neoplasia (10%) 
and three protein energy wasting (10%). Pre-HD OER values were negatively associated with all-cause mortality 
in univariate (HR = 0.9, CI 0.82–0.98, p = 0.015) and multivariate analysis adjusted for age, sex, diabetes and dial-
ysis duration (HR = 0.88, CI 0.79–0.99, p = 0.028). Similarly, associated with mortality in univariate (HR = 1.04, 
CI 1.01–1.08, p = 0.011) and multivariate adjusted analysis (HR = 1.04, CI 1.01–1.08, p = 0.015), was the percent 
HD-induced OER increment, this time with a positive relationship. To evaluate if OER distinguished different 
populations, we considered two groups of patients according to pre-HD OER and HD-related OER changes. As 
illustrated in Table 4, pre-HD OER < 32% and percent OER increments > 40% were both associated with signif-
icantly greater mortality (p < 0.01 for both). These results were confirmed in the corresponding survival curves 
(Kaplan-Meier log rank test = 0.021 and 0.043 respectively for pre-HD and percent OER increments) (Fig. 6a,b).
Discussion
In our study, we demonstrate that OER changes significantly during HD sessions, is not affected by the interdi-
alytic shifts of patient’s hydration status, is differently induced by iD and iUF and is stable and repeatable in the 
individual patient. Further, we found a significant association of both pre-HD OER and percent increments of 
Figure 3. OER increment during iD was greater than during iUF (ANOVA p < 0.04) and was significantly 
different after 15′ and 30′ but not after 60′. Bonferroni post-hoc test, iD vs iUF: *p < 0.05; #p < 0.01.
HD session 0′ 15′ 30′ 60′ 120′ 240′ Anova
HDShort, iUF 33.0 ± 1.4 35.9 ± 1.5 36.6 ± 1.4 37.5 ± 1.5 42.3 ± 1.8° 47.2 ± 2.0° 0.001
HDShort, iD 32.4 ± 1.4 37.6 ± 1.4 38.8 ± 1.1* 38.4 ± 1.5* 42.3 ± 1.9° 46.4 ± 1.6° 0.001
Table 3. OER values (M ± SE) during iD and iUF sessions in 20 patients. Bonferroni Post-hoc test vs basal 
values: *p < 0.05; °p < 0.001.
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OER with all-cause mortality. Therefore, resting OER and OER increments can be considered potentially useful 
biomarkers of the oxygen needs in uremia and of the HD-related hypoxic stress, possibly helpful to stratify mor-
tality risk in the individual patient.
Our data indicate that, by means of OER progression during sessions, we can easily quantify the commonly 
appreciated intradialytic increment in oxygen need4,12. Further, the evidence that the average shifts in hydration 
status occurring within dialysis treatments do not affect the process of oxygen extraction, suggests that we could 
obtain the resulting clinical information in any weekly session, at least in experimental conditions like ours (i.e. 
with moderate UF rate and in the absence of intradialytic symptoms). The evidence in our study that dialysis 
procedure per se, even without UF, plays a significant role in the increment of OER is original. In fact, in our 
observation OER increased significantly since after 30′ of iD and, remarkably, in higher amounts than it did with 
iUF. This iD-related quick increment indicates that, in the absence of UF, factors like biocompatibility13, pH14 
and electrolyte15 shifts, increase the need of oxygen at tissue level, more than iUF does. Indeed, the recorded 
increment in oxygen extraction with iUF was slower, pointing to a reduced or smoother hypoxic stress, and this 
finding is in agreement with the common observation of improved hemodynamic stability during iUF dialysis.
Importantly, the temporal changes of OER in our study, within 30 minutes of HD, correspond with the reduc-
tion of microvascular perfusion and of parenchymal myocardial function evidenced in HD patients only by 
means of Magnetic Resonance Imaging (MRI), and not by standard parameters (like blood pressure and heart 
rate)1,16. Similarly, a PET scan after 30′ of iD without UF evidenced a significant reduction of regional myocardial 
blood flow17. Since it is possible that an increased oxygen consumption would precede or associate with episodes 
of tissue ischemia, we can hypothesize that OER could unravel patients suffering or at increased risk of dialysis 
induced tissue hypoxia. The quick increment of OER described in our study becomes thus a plausible biomarker 
of dialytic stress, helpful to find out, in the individual patient, the possibly involved factor among those commonly 
claimed to explain dialysis related morbidity. In our opinion, the evidence produced by MRI and PET that the 
ischemic burden of HD occurs early, reinforces the diagnostic potential of OER as a marker of hypoxia.
Figure 4. Individual variability (Median, IQ50%, and range) of pre- and post-HD OER in each of the ten 
patients recorded ten times. Maximal variation over time of pre-HD values was estimated to be 6.6%. Values are 
shown in increasing order of pre-HD OER.
Figure 5. In ten patients, each evaluated ten consecutive times, mean pre-HD OER was strongly and negatively 
correlated with percent increments.
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Another original and important finding in our study is that pre-HD OER is sufficiently stable and repeatable 
in the single patient. This suggests that OER could be used as a routine tool of clinical stability in our fragile 
patients. Importantly and unexpectedly, pre-HD OER levels in our patients were higher than the commonly 
accepted normal reference (i.e. 20–30%) and reached post-HD values that, in ICU, are considered diagnostic of 
hemodynamic shock. Since none of our patient was symptomatic or suffered congestive heart failure or COPD 
and all of them had adequate peripheral oxygenation (evidenced by normal SaO2), this must be related to reduced 
ScvO2 even before starting treatment. Indeed, resting ScvO2 in our patients averaged 67 ± 1.7.% which is lower 
than the 70% threshold recommended (together with low Hb) by the American Heart Association to decide blood 
transfusion in critically ill children18. Recently, in 232 HD patients with CVC as vascular access, Chan et al.19 
evaluated retrospectively the association between ScvO2 and mortality. With an observation period of 3 years, 
they found better survival in those patients in the upper tertiles of ScvO2. Given the strict relationship between 
ScvO2 and OER, our hypothesis that OER could be a useful diagnostic tool in HD is confirmed. Conceptually, as 
the same Authors of this paper underline, OER is more precise and reliable than ScvO2 since it also includes the 
measurement of peripheral arterial oxygenation (SaO2). In addition, in our study patients with higher pre-HD 
OER values had lower increments at the end of treatment, while those with lower pre-HD OER values (within 
normal range) were apparently able to increase definitely better the extraction of oxygen from peripheral blood, as 
predictable in normal subjects8. Alternatively, the latter group seems to face a significantly higher hypoxic burden. 
While the clinical relevance of this inverse relationship deserves better appreciation, it clearly indicates that the 
adaptive response to hypoxia during HD can be quite different among patients and that OER could be helpful to 
distinguish them. Hypothetically, the OER response could characterize those at increased risk of asymptomatic, 





p<OER ≤ 32% (15) OER > 32% (15) Delta OER ≥ 40% (14) Delta OER ≤ 40% (16)
Men/Females; n (%) 8 (53)/7 (47) 5 (33)/10 (66) 7 (50)/7(50) 6 (37)/10 (63)
Age, yr 76 ± 3.0 73 ± 3.4 n.s 75 ± 3 76 ± 3 n.s
Vintage HD, yr 3.0 ± 0.7 4.0 ± 0.6 n.s 3.0 ± 0.7 3.5 ± 0.6 n.s
Comorbidities; n (%) 7 (46) 8 (53) n.s 6 (42) 9 (68) n.s
- Obesity (BMI > 30) 0 3 (20) 1 (7) 2 (12)
-Diabetes, n (%) 7 (46) 4 (26) 7 (50) 4 (25)
- Vascular co-morbidities* 3 (20) 5 (33) 4 (28) 4 (25)
Follow-up, months, (range) 12 ± 2.2 (23–3) 19 ± 1.1 (23–3) n.s 14 ± 1,6 (21–3) 16 ± 2 (23–3) n.s
All-cause mortality, n (%) 10 (67) 3 (20) 0.01 9 (64) 4 (25) 0.01
- Infection 3 (20) 1 (7) 3 (33) 1 (25)
- Acute coronary syndrome 3 (20) 0 2 (22) 1 (25)
- Neoplasia 2 (13) 1 (7) 2 (22) 1 (25)
- Protein energy wasting 2 (13) 1 (7) 2 (22) 1 (25)
OER first measurement, % 27 ± 0.8 37 ± 1.3 0.001 29 ± 1 36 ± 2 0.001
Delta OER, % 48 ± 5.2 33 ± 4.7 0.04 59 ± 2 24 ± 2 0.001
OER LOCF#, % 34 ± 2.2** 38 ± 1.7 n.s 37 ± 2.4** 35.0 ± 1.6 n.s
Tabelle 4. Clinical and biochemical characteristics of population divided according to pre-HD and delta OER 
value. Data are M ± SE. (*)Vascular co-morbidities = Peripheral ischemia and acute Coronary Syndrome§; 
(#)LOCF: last observation carried forward. All comparisons are t-test, except for X2 test (#) applied for 
comorbidities and mortality. (**)p < 0.01 vs OER first measurement.
Figure 6. Survival curve according to pre-HD OER (a) and HD-related percent OER increments (b). Mortality 
rate was significantly greater in patients with pre-HD OER < 32% and in those with delta OER > 40%.
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recognize among anemic children receiving cardiac surgery those who would benefit most from blood trans-
fusions20, and to be a major determinant of exercise capacity in adult patients with heart failure and preserved 
ejection fraction21. These clinical observations further underline the potential usefulness of OER.
Importantly, in our study OER values associated with mortality. The negative association of pre-HD OER (i.e., 
lower values = higher mortality) are at variance with the abovementioned data by Chan et al.19 showing better 
survival of patients in the higher SCVO2 tertile (then with presumably lower OER). However, the population in 
that study is definitely younger than our and does not show the substantial reduction of ScvO2 at the end of dialy-
sis, invariably described in the literature4,7. In any case, since uremia is generally regarded as a clinical condition of 
increased oxygen demands7, an adaptive response which increases OER even in resting condition seems plausible 
and in accordance with the general finding of invariably low pre-HD ScvO2 values in HD patients4,12,19. Therefore, 
having lower values could also indicate absent or insufficient adaptation to uremia. As for the positive associa-
tion of delta OER with mortality, it seems much easier to explain since it is in agreement with the hypothesis of 
increased hypoxic stress during dialysis and, eventually, with the finding of increased morbidity and mortality. 
All in all, our data suggest that adapted patients (those with increased pre-HD OER) suffer less the HD-related 
hypoxic stress (lower OER increments) as compared to not-adapted (or maladapted/not-still-adapted) patients.
A practical final consideration to do is that OER measurement does not imply cost increments, is easily acces-
sible to most if not all of the dialysis units, and is conceptually sound to appreciate the recently revealed impor-
tance of intra-dialysis tissue hypoxia.
Our study has limitations. The number of patients included in the follow-up data is rather low to firmly estab-
lish if OER associates with dialysis-related hard-outcomes. However, our pilot study can be regarded as essential 
to unravel the behavior of a parameter never evaluated before in HD patients. As such, it is preliminary to any 
large prospective clinical study. Another limitation is that we did not measure the time and rate of OER recovery 
in the hours following HD treatment. While such an observation would have made the study more complete and 
could have ruled out if, by chance, the OER recovery-time overlaps with the so called “post-HD fatigue” thus 
reinforcing its role as a biomarker, it is certainly not essential for our conclusions. Finally, since OER can be meas-
ured only in patients with CVC who may suffer from increased cardiovascular complications, it must be regarded 
as limited to this type of patients and then of reduced practical application. However, while the prevalence of 
patients with permanent CVC is not marginal, the clinical information obtainable with OER in these patients 
could be translated to those with a fistula as vascular access. Further, recent researches suggest that peripheral 
venous O2 saturation could be measured non-invasively thus allowing to estimate peripheral oxygen extraction 
in patients without central vein catheterization22.
Strengths of our study include the prospective design and the originality of the observation, which allowed to 
characterize, for the first time in HD patients, the performance of OER.
We conclude that in HD patients with CVC as vascular access, OER is an easy, cheap, measurable and repeat-
able parameter that reflects the intra-HD related parenchymal hypoxic stress. The consistency of the results with 
available clinical studies on intradialytic ischemia and the number of potential clinical applications of OER sug-
gested by our results, claim for further observations and developments for this parameter.
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